Novatek Microelectronics Corp (聯詠), a supplier of display driver ICs, yesterday said that its revenue would plunge as much as 39 percent this quarter as customers pare down orders amid tepid demand for smartphones and other consumer electronics due to a global economic upheaval.
A spike in supply chain inventory is also adding to the already weak momentum of the industry, Novatek told an online investors’ conference.
However, the Hsinchu-based company said that this quarter would be the trough for the year as it is pinning its hopes on new product launches by smartphone vendors to help recoup some losses in revenue next quarter.
Photo: Grace Hung, Taipei Times
“The company is entering a revenue correction period in the second half of this year as demand slumps and inventory piles up,” Novatek president Steven Wang (王守仁) said.
Revenue this quarter is to plunge to between NT$19.1 billion and NT$20.3 billion (US$637.73 million and US$677.80 million), a quarter-on-quarter decline of between 35 and 39 percent from NT$31.46 billion in the second quarter, the company said.
The company’s revenue last month tumbled 15.84 percent month-on-month and 45.07 percent year-on-year to NT$6.87 billion, Novatek said in a statement.
Demand for all three of the company’s product lines is on the wane, extending a downtrend in the second quarter, Novatek said.
Display driver ICs are to suffer the brunt in terms of volume and prices, the company said.
Small display driver ICs for mobile phones were the largest contributor to revenue last quarter, accounting for 39 percent. TV chips had a 33 percent share, while display driver ICs used in TV panels made up the remaining 28 percent, it said.
Gross margin is to dip to between 42 and 44 percent this quarter, after registering a 4.35 percentage points decline to 47. 62 percent last quarter, the company said.
Novatek expects the downtrend to carry into next quarter, but it would be a less drastic decline as it attempts to negotiate lower wafer prices to cut costs.
Novatek said it is in talks with suppliers of raw materials such as wafers to have some flexibility in executing their supply agreements. The company has included provisions for not fully honoring the agreements in the third-quarter forecast.
The company said a complete inventory adjustment would take two quarters.
Novatek booked a higher-than-normal level of inventory of NT$18.8 billion last quarter, which translates to 103 days.
Novatek offered the bleak outlook for the current quarter after reporting disappointing quarterly earnings. Revenue contracted 13.83 percent quarter-on-quarter and 7.77 percent year-on-year to NT$31.46 billion in the second quarter, missing the company’s target of NT$34.5 billion.
Net profit contracted 13.28 percent year-on-year to NT$8.49 billion last quarter, a quarter-on-quarter decline of 23.78 percent from NT$11.13 billion.
Earnings per share fell to NT$13.95 last quarter, compared with NT$16.08 a year earlier and NT$18.3 a quarter earlier.
RECOVERED CONFIDENCE: As market rationality returns, Taiwanese stocks that have lagged behind their US peers might soon catch up, Allianz researchers said Local shares last week defied heavy pressure from China’s military drills in waters around Taiwan, and investors this week are expected to pay attention to earnings results from several tech heavyweights as well as the latest economic data on exports and GDP. The TAIEX closed at 15,036.04 points on Friday, posting a weekly increase of 0.24 percent from 15,000.07 on July 29, Taiwan Stock Exchange data showed. Over the same period, the FTSE TWSE Taiwan 50 Index, which comprises Taiwan’s top 50 stocks in terms of market capitalization, closed up 0.93 percent at 11,750.15 points, while the Formosa Stock Index, which measures
Pharmaceutical start-up AcadeMab Biomedical Inc (研生生醫) said it has been developing a COVID-19 antibody drug, an endeavor not being undertaken by many other Taiwanese pharmaceutical firms. The company was spun off from Academia Sinica’s Institute of Cellular and Organismic Biology in 2020 and has only 16 employees. It has set its sights on the innovative field of the monoclonal antibody treatment of tumors. The start-up began developing antibody drugs in January, after seeing that COVID-19 vaccines could not effectively protect people from new variants of SARS-CoV-2, AcadeMab Biomedical chief strategy officer Pearl Fong (俸清珠) said in an interview with the Taipei Times
FORECAST EXCEEDED: China’s curbs on some Taiwanese goods are unlikely to affect trade given inter-reliance in the electronics industries, a finance ministry official said Exports last month spiked 14.2 percent to US$43.32 billion, the second-highest increase on record and the 25th consecutive month of gains, driven by global demand for electronics used in high-performance computing and vehicles, the Ministry of Finance said yesterday. The ministry expects the trend to sustain this month and beyond, although the pace could slow due to inventory corrections for laptops, smartphones and other consumer electronics. “The July results proved stronger than expected despite rising fears over economic uncertainty,” Department of Statistics Director-General Beatrice Tsai (蔡美娜) said, adding that a high sales season in the West and stabilized COVID-19 infections in China
Government officials and business representatives yesterday participated in a groundbreaking ceremony at the Nanzih Technology Industrial Park (楠梓科技產業園區) in Kaohsiung, where Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) is to construct a 12-inch wafer plant. The 238-hectare park sits on the former site of a naphtha cracking plant owned by state-owned oil refiner CPC Corp, Taiwan (台灣中油). Thirty hectares of the first phase of development are reserved for TSMC’s planned factory, while the second phase is to be occupied by international semiconductor material and equipment companies, the Executive Yuan said in a statement yesterday. “The park will be connected with Tainan Science Park